Table 1. Correlation between miR-329 expression and clinicopathological parameters of NSCLC patients(n=26).
Parameter | n | Relative miR-329 expression | ||
---|---|---|---|---|
Low | High | P-value | ||
Age/years | 0.0895[b] | |||
≤ 65 | 8 | 2 | 6 | |
> 65 | 18 | 12 | 6 | |
Gender | 0.1696[b] | |||
Male | 20 | 9 | 11 | |
Female | 6 | 5 | 1 | |
Differentiation | 0.7558[a] | |||
Well, moderate | 16 | 9 | 7 | |
Poor | 10 | 5 | 5 | |
Tumor size (maximum diametercm) | 0.0079[*][b] | |||
≤ 3cm | 14 | 4 | 10 | |
> 3cm | 12 | 10 | 2 | |
Smoking history | 0.2164[b] | |||
Smokers | 18 | 8 | 10 | |
Never smokers | 8 | 6 | 2 | |
Lymph node metastasis | 0.0162[*][b] | |||
Positive | 15 | 11 | 3 | |
Negative | 11 | 3 | 9 | |
TMN stage | 0.0048[*][b] | |||
I | 13 | 3 | 10 | |
II/III/IV | 13 | 11 | 2 | |
Histological tumor type | 0.9512[a] | |||
Squamous cell carcinoma | 11 | 6 | 5 | |
Adenocarcinoma | 15 | 8 | 7 |
Chi-square test
Fisher's exact test
P < 0.05